Compare Stitch Fix Inc (SFIX) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stitch Fix Inc vs Zimmer Biomet Holdings Inc — how do they compare? Stitch Fix Inc trades at $3.94 (market cap $520.36M), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 33.4× Stitch Fix Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.07% dividend while Stitch Fix Inc pays none. Which is the better fit depends on your goals.
| SFIX | ZBH | |
|---|---|---|
Market Cap | $520.36M | $17.36B |
Sector | Consumer Cyclical | Health |
52-Week High | $5.83 | $107.71 |
52-Week Low | $3.06 | $79.58 |
Enterprise Value | $408.08M | $24.40B |
Dividend Yield | — | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stitch Fix (SFIX) trades at $3.84, up 1.32% today, showing signs of stabilization after a challenging period. The stock exhibits a bullish technical signal with improving fundamentals, including narrowing losses and a debt-free balance sheet. Recent quarters show earnings beats, with Q1 2026 actual EPS of -$0.01 beating expectations of -$0.06. Revenue remains stable at $1.27 billion for 2025, while net losses have decreased significantly from -$207 million in 2022 to -$28.74 million in 2025. AI-driven personalization initiatives and active client growth are key positive developments.
The outlook for SFIX is cautiously optimistic as the company's turnaround gains traction. Investment opportunities include potential upside to the $4.75 consensus price target, representing 24% upside, and continued margin improvement. Risks include persistent net losses, competitive pressures in online retail, and sensitivity to consumer spending trends. The stock's low P/S ratio of 0.39 suggests undervaluation if the recovery continues, but execution risks remain substantial.
Zimmer Biomet (ZBH) trades at $88.92, down 2.41% on the day, with a bearish technical signal but strong fundamentals including a 70.03% gross margin and three consecutive quarterly EPS beats. Revenue grew to $8.23B in 2025, though net income margin compressed to 8.56%. The company announced a $1 billion share repurchase increase and expansion in India, while maintaining a dividend.
The stock offers a 10% upside to the $97.67 consensus price target, supported by value metrics and operational strength, but faces risks from rising debt levels and competitive pressures. Analyst sentiment is mixed with 40% buy ratings, suggesting cautious optimism amid near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
